UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Astellas Korea names Masujima Keita as new CEO
Astellas Korea said Thursday it appointed Masujima Keita as its new chief e...
by Lee Han-soo
|
2019-04-01 11:02
라인
Bayer reports 8th-consecutive-year growth in Asia-Pacific
Bayer Korea said Friday that 2018 was another year of robust growth for its...
by Lee Han-soo
|
2019-04-01 11:02
라인
LG Chem, Sprint to co-develop NASH treatment
LG Chem said Friday that it has signed a contract with Sprint Bioscience to...
by Lee Han-soo
|
2019-04-01 11:01
라인
‘Expanded reimbursement for Prolia to give more options to osteoporosis patients’
Amgen Korea said Friday Prolia (ingredient: denosumab), a biological agent ...
by Lee Han-soo
|
2019-03-29 18:32
라인
Phase-3 trials of Huntington’s chorea treatment approved
The government has granted the nod to go ahead with phase-3 trials on deute...
by Lee Hye-seon
|
2019-03-29 17:24
라인
Il-yang to research Parkinson’s disease in Europe
Il-yang Pharmaceutical said Wednesday that it plans to start full-fledged c...
by Lee Han-soo
|
2019-03-28 16:28
라인
Allergan to resume marketing of macular edema treatment
Allergan Korea said Tuesday that it has started re-marketing Ozurdex (ingre...
by Lee Han-soo
|
2019-03-27 16:55
라인
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe
JW Life Science said it has become Asia’s first pharmaceutical firm to sell...
by Jeong Sae-im
|
2019-03-27 16:16
라인
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment
CrystalGenomics said Tuesday that Aptose Bioscience, its U.S. partner, has ...
by Lee Han-soo
|
2019-03-27 15:58
라인
‘Remimazolam has fewer side effects than propofol’
Hana Pharma said its new general anesthetic drug remimazolam demonstrated e...
by Jeong Sae-im
|
2019-03-27 15:05
라인
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has published a phase 3 clinical trial f...
by Lee Han-soo
|
2019-03-27 14:52
라인
AstraZeneca to launch Imfinzi in Korea next month
AstraZeneca said it would launch Imfinzi (ingredient: durvalumab), an immun...
by Lee Han-soo
|
2019-03-27 14:52
라인
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis
Hanlim Pharm said it would test HL301, a drug candidate for bronchitis, to ...
by Lee Hye-seon
|
2019-03-26 15:57
라인
Doctors outrageous over MSD Korea’s recordings of their talks
Korean doctors are enraged, criticizing MSD Korea’s alleged collection of f...
by Park Gi-taek
|
2019-03-25 16:05
라인
Daewoong releases P3 trial results for Nabota
Daewoong Pharmaceutical said Monday that it has published the U.S. phase 3 ...
by Lee Han-soo
|
2019-03-25 15:01
라인
Regulator OKs immunotherapies developed by multinational pharma companies
The Ministry of Food and Drug Safety (MFDS) approved Bavenico, a monoclonal...
by Lee Han-soo
|
2019-03-25 11:28
라인
Otsuka Korea CEO receives presidential citation
Otsuka Korea said Friday that Moon Sung-ho, the company’s CEO, received a p...
by Lee Han-soo
|
2019-03-22 16:52
라인
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials
Biogen announced on Thursday that it would discontinue the phase-3 trials o...
by Kim Yun-mi
|
2019-03-22 15:50
라인
Eubiologics gets nod to test botulinum toxin in phase-1 study
Eubiologics said it has begun developing a botulinum toxin product.The Mini...
by Lee Hye-seon
|
2019-03-22 15:28
라인
‘MSD Korea excessively monitors workers, collects client info without consent’
MSD Korea used to be called one of the best workplaces in the pharmaceutica...
by Jeong Sae-im
|
2019-03-22 13:49
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top